Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Bonham
Antileukemic Activity of Lysophosphatidic Acid Acyltransferase- Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Characteristics of Dasatinib- And Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Clinical Cancer Research
Cancer Research
Oncology
Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia
Clinical Journal of Oncology Nursing
Oncology
An Analysis of Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia With Imatinib-Resistant Mutations
Mathematical Biosciences
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Simulation
Immunology
Biological Sciences
Medicine
Agricultural
Modeling
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Increased Cortical Bone Mineralization in Imatinib Treated Patients With Chronic Myelogenous Leukemia
Haematologica
Hematology
Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments
Efficacy of the Dual PI3K and mTOR Inhibitor NVP-BEZ235 in Combination With Imatinib Mesylate Against Chronic Myelogenous Leukemia Cell Lines
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Chronic Myelogenous Leukemia
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Lysophosphatidic Acid Acyltransferase Beta Regulates mTOR Signaling
PLoS ONE
Multidisciplinary